IMMATICS BIOTECHNOLOGIES GMBH
IMTXW -0.31
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 5.9M |
| Cost of Revenue | 30.5M |
| Gross Profit | -24.6M |
| Operating Expense | 39.2M |
| Operating I/L | -33.3M |
| Other Income/Expense | 6.8M |
| Interest Income | 4.0M |
| Pretax | -26.5M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -26.5M |
immatics biotechnologies GmbH
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
